In conclusion, long-term stimulation with tumor antigens might lead to increased expression of BCL10, and suppress CD8+ T cells, Th1 cells, and NKT cells while promoting Treg and Th2 cell expansion across multiple tumor types. Here, BCL10 is linked to neoplasm.